ARS PHARMACEUTICALS INC (SPRY:NASDAQ)
$7.94 0.06 (0.7614%)
Analysed ARS PHARMACEUTICALS INC (SPRY:NASDAQ) News Sources
Drew Brees Collaborates with ARS Pharmaceuticals to Raise Awareness About Living Life with Severe Allergies
04-06-2026
yahoo.com
How The Evolving Story For ARS Pharmaceuticals (SPRY) Could Shape Future Valuation
09-06-2026
yahoo.com
ARS Pharmaceuticals Provides Commercial and Financial Updates
24-06-2026
yahoo.com
SPRY Stock Tanks Over 23% After-Hours — ARS Pharmaceuticals Reports No New Major Insurance Wins For Neffy
25-06-2026
stocktwits.com
SPRY, PASG, BOXL: Why These Stocks Plunged Double Digits In After-Hours Trading Today
25-06-2026
stocktwits.com
Micron Sparks Fresh AI Stock Rally
25-06-2026
yahoo.com
ARS Pharma Collapses After CVS Punts Its Epinephrine Spray Decision To January
25-06-2026
yahoo.com
ARS Pharmaceuticals (SPRY) Is Down 11.5% After Losing Spots in Key Russell 2000 Defensive Indices
29-06-2026
yahoo.com
ARS Pharmaceuticals Announces CEO Succession
07-07-2026
yahoo.com
Strength Seen in CRINETICS PHARM (CRNX): Can Its 98.7% Jump Turn into More Strength?
08-07-2026
yahoo.com
What is the current price of ARS PHARMACEUTICALS INC (SPRY:NASDAQ)?
The current price of ARS PHARMACEUTICALS INC (SPRY:NASDAQ) is $7.94.
ARS PHARMACEUTICALS INC (SPRY:NASDAQ) absolute price change since previous trading day?
The absolute price change of ARS PHARMACEUTICALS INC (SPRY:NASDAQ) since the previous trading day is $0.06.
ARS PHARMACEUTICALS INC (SPRY:NASDAQ) percentage price change since previous trading day?
The percentage price change of ARS PHARMACEUTICALS INC (SPRY:NASDAQ) since the previous trading day is 0.7614%.
What is the most recent average sentiment score for ARS PHARMACEUTICALS INC (SPRY:NASDAQ)?
The most recent average sentiment score for ARS PHARMACEUTICALS INC (SPRY:NASDAQ) is 48 out of 100.
What is the most recent average sentiment for ARS PHARMACEUTICALS INC (SPRY:NASDAQ)?
The most recent sentiment for ARS PHARMACEUTICALS INC (SPRY:NASDAQ) is .
SEC-8K** Filing Available For ARS PHARMACEUTICALS INC (SPRY:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.